What does a urine albumin:creatinine (A:C) ratio of 148mg/mmol indicate in a 52-year-old individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Urine Albumin:Creatinine Ratio of 148 mg/mmol

A urine albumin:creatinine ratio (UACR) of 148 mg/mmol indicates severely increased albuminuria (macroalbuminuria), which represents significant kidney damage and requires immediate medical intervention. 1

Classification and Significance

According to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines, albuminuria is categorized as follows:

  • A1 (Normal to mildly increased): <30 mg/g (<3 mg/mmol)
  • A2 (Moderately increased): 30-299 mg/g (3-29 mg/mmol)
  • A3 (Severely increased): ≥300 mg/g (≥30 mg/mmol) 1

At 148 mg/mmol, this patient's result falls well into the A3 category (severely increased albuminuria), as it is significantly above the 30 mg/mmol threshold.

Clinical Implications

This level of albuminuria indicates:

  1. Established kidney damage: This represents significant glomerular injury with increased permeability to albumin 1, 2

  2. High risk for CKD progression: The patient is at substantially increased risk for progressive decline in kidney function 1

  3. Elevated cardiovascular risk: Severely increased albuminuria is an independent risk factor for cardiovascular events and mortality 2, 3

  4. Need for confirmation: Due to high biological variability (>20%) in urinary albumin excretion, this finding should be confirmed with 1-2 additional tests over a 3-6 month period to establish persistence 1

Recommended Follow-up Actions

  1. Repeat testing: Confirm the elevated UACR with 1-2 additional measurements within 3-6 months 1

  2. Comprehensive kidney function assessment:

    • Measure estimated glomerular filtration rate (eGFR)
    • Complete urinalysis to check for hematuria or other abnormalities
    • Assess for other markers of kidney damage 1
  3. Medication management:

    • Initiate or optimize ACE inhibitor or ARB therapy (strongly recommended for UACR ≥300 mg/g) 1
    • Target blood pressure <130/80 mmHg 2
    • Monitor serum creatinine and potassium levels regularly when using these medications 1
  4. Nephrology referral:

    • Prompt referral is indicated, especially if eGFR <30 mL/min/1.73 m² 1
    • Also refer for rapidly declining kidney function or uncertainty about etiology 1
  5. Risk factor modification:

    • Optimize glycemic control (target HbA1c <7%) if diabetic 2
    • Implement dietary sodium restriction (<2.0 g/day) 2
    • Recommend smoking cessation 2
    • Manage lipids (target LDL <100 mg/dL) 2

Important Considerations

  • Potential false positives: Exercise within 24 hours, infection, fever, heart failure, marked hyperglycemia, menstruation, and severe hypertension can transiently elevate UACR 1

  • Variability: There is high within-individual variability in UACR measurements (coefficient of variation up to 48.8%), which is why confirmation with multiple samples is important 4

  • Monitoring frequency: Once confirmed, UACR should be monitored every 3-6 months to assess disease progression and treatment response 2

  • Treatment goal: Aim for at least a 30% reduction in UACR with treatment, with an ideal target of achieving UACR <30 mg/g 1

This level of albuminuria requires prompt attention as it indicates significant kidney damage and increased risk for both kidney disease progression and cardiovascular events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Proteinuria Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Microalbuminuria: what is it? Why is it important? What should be done about it?

Journal of clinical hypertension (Greenwich, Conn.), 2001

Research

Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.